Two recent randomized clinical trials (RCTs) [1,2] are likely to influence upcoming Hypertension Guidelines regarding the blood pressure (BP) targets. The important findings of these two studies should be considered in the context of available randomised clinical trials comparing different BP targets [3,4].
